Science Explorer Interactive view Map
Company · Rockville · United States

Immunomic Therapeutics (United States)

immunomix.comROR OpenAlex
Research works
27
▲ 297% vs 2013–17
Citations
564
21.2 per fractional work
Top-10% rate
41.6%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: Immunomic Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.27× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.46× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 13.33× its world share, 1 worksImmunology and Micro…Neuroscience: 1.58× its world share, 0 worksNeuroscienceComputer Science: 0.88× its world share, 0 worksComputer ScienceEnvironmental Science: 0.51× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.39× its world share, 0 worksHealth ProfessionsMedicine: 2.48× its world share, 3 worksMedicineSocial Sciences: 0.48× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.3×. Every wedge is a field page.

Which keywords describe research at Immunomic Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Cancer Immunotherapy, Innate Immunity, Antigen Presentation, Immunity, Immunotherapy, Tumor Regression and Dendritic Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Gene Therapy4▲ 63×3 topics
  2. Epidemiology4▲ 3.5×13 topics
  3. Cancer Immunotherapy4▲ 98×2 topics
  4. Innate Immunity4▲ 39×3 topics
  5. Antigen Presentation3▲ 112×2 topics
  6. Immunity3▲ 32×2 topics
  7. Dendritic Cells3▲ 92×1 topic
  8. Immunotherapy3▲ 16×2 topics
  9. Tumor Antigen3▲ 130×1 topic
  10. Tumor Regression3▲ 122×2 topics
  11. Antiviral Therapy3▲ 66×2 topics
  12. Transplant Recipients3▲ 119×2 topics
  13. Vaccine Development3▲ 32×4 topics
  14. Hearing Loss2▲ 62×2 topics
  15. Cytomegalovirus2▲ 187×1 topic
  16. Infection2▲ 31×1 topic
  17. Bacterial Therapy2▲ 172×1 topic
  18. Tumor Targeting2▲ 57×1 topic
  19. AAV2▲ 99×1 topic
  20. Viral Vectors2▲ 99×1 topic
  21. Genomics2▲ 17×3 topics
  22. Quality of Life1▲ 3.6×3 topics
  23. Virus1▲ 41×3 topics
  24. Bacteriophage1▲ 67×1 topic
  25. Diagnosis1▲ 4.5×3 topics
  26. Ecology1▲ 21×1 topic
  27. Immune Response1▲ 7.3×6 topics
  28. Lymphoma1▲ 29×2 topics
  29. Metagenomics1▲ 38×2 topics
  30. Nanoparticles1▲ 3.4×2 topics
  31. Allergen-specific Immunotherapy1▲ 94×1 topic
  32. Anaphylaxis1▲ 136×1 topic
  33. Asthma1▲ 30×1 topic
  34. Food Allergy1▲ 136×1 topic

Which research topics does Immunomic Therapeutics (United States) publish most on?

By volume in 2022–2025: Immunotherapy and Immune Responses, RNA Interference and Gene Delivery, CAR-T cell therapy research and Polyomavirus and related diseases.

Immunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksRNA Interference and Gene Delivery: 0 fractional worksCAR-T cell therapy research: 0 fractional worksPolyomavirus and related diseases: 0 fractional worksVaccine Coverage and Hesitancy: 0 fractional worksHepatitis B Virus Studies: 0 fractional worksVirology and Viral Disea…0Virology and Viral Diseases: 0 fractional worksHerpesvirus Infections and Treatments: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksCytomegalovirus and herp…0Cytomegalovirus and herpesvirus research: 0 fractional works
ImmunologyMolecular BiologyOncologyHealth2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 1 works
  2. 2 RNA Interference and Gene Delivery Molecular Biology 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Polyomavirus and related diseases Oncology 0 works
  5. 5 Vaccine Coverage and Hesitancy Health 0 works
  6. 6 Hepatitis B Virus Studies Epidemiology 0 works
  7. 7 Virology and Viral Diseases Epidemiology 0 works
  8. 8 Herpesvirus Infections and Treatments Epidemiology 0 works
  9. 9 Chronic Lymphocytic Leukemia Research Genetics 0 works
  10. 10 Cytomegalovirus and herpesvirus research Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.7%not open54.3%

World: 28% of research is openly available.

with international co-authors14.6%domestic only85.4%

World: 19% is written across borders.

How has Immunomic Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 297% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rockville

All research institutions in Rockville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.